In recent years many different nanotechnology platforms have been developed for both diagnostics
and cancer therapy. Researchers have been attracted to use lipid-based nanoparticles with
particle size approximately 100 nm as a new pharmaceutical delivery system or pharmaceutical formulation
that can be assembled from different types of lipid or other chemical components in order to
overcome biological barriers. This mini-review highlights the recently published studies in the development
of lipid-based nanoparticles as appropriate vehicles in cancer diagnosis and therapy with focus
on their chemical structure, formulation recipes, stability, drug encapsulation, and other factors related
to their formulation.
Keywords: Drug delivery, lipid, lipid-based nanoparticles (LNPs), liposome, solid lipid nanoparticle (SLN), nanotechnology.
Rights & PermissionsPrintExport